Drug recall · October 10, 2018
Clozapine Orally Disintegrating Tablets recall
Why: Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.
- Lots / codes
Lot #: 34034024B, Exp 02/20
- Quantity
- 313 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Distributed nationwide in the USA
- Initiated
- September 21, 2018 · Voluntary: Firm initiated
- Classified
- October 1, 2018
- Reported
- October 10, 2018
- Ended
- May 1, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clozapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.